BackMersana Therapeutics Overview

Mersana Therapeutics Cost of Revenue

Cost of Revenue analysis for MRSN.

Quarterly Cost of Revenue

N/A

As of Sep 30, 2025

Annual Cost of Revenue (TTM)

$287000.00
↓ 77.45% YoY

Trailing 12 months ending Sep 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin